← United States · Coverage record
US · SEC FORM 4
Oscar Health, Inc.
OSCR · NYSE · CIK 0001568651 · Healthcare · Healthcare Plans
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
65 Form 4 transaction lines observed in the same window
44 sales · 21 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-04-06 · Bertolini Mark T.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 16,451,694
- Previous report
- 17,770,151
- Avg daily volume
- 6,135,580
- Days to cover
- 2.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | Bertolini Mark T | Purchase (P) | Class A Common Stock | 1,000,000 | USD 11.92 | USD 11,920,000 | SEC filing ↗ |
| 2024-11-21 | Kushner Joshua | Purchase (P) | Class A Common Stock | 100,000 | USD 16.86 | USD 1,686,000 | SEC filing ↗ |
| 2024-11-21 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 100,000 | USD 16.86 | USD 1,686,000 | SEC filing ↗ |
| 2024-11-20 | Kushner Joshua | Purchase (P) | Class A Common Stock | 88,395 | USD 16.97 | USD 1,500,063 | SEC filing ↗ |
| 2024-11-20 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 88,395 | USD 16.97 | USD 1,500,063 | SEC filing ↗ |
| 2024-11-14 | Kushner Joshua | Purchase (P) | Class A Common Stock | 344,522 | USD 15.80 | USD 5,444,873 | SEC filing ↗ |
| 2024-11-14 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 344,522 | USD 15.80 | USD 5,444,873 | SEC filing ↗ |
| 2024-11-13 | Kushner Joshua | Purchase (P) | Class A Common Stock | 358,619 | USD 13.74 | USD 4,927,425 | SEC filing ↗ |
| 2024-11-13 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 358,619 | USD 13.74 | USD 4,927,425 | SEC filing ↗ |
| 2024-11-12 | Kushner Joshua | Purchase (P) | Class A Common Stock | 420,819 | USD 13.68 | USD 5,756,804 | SEC filing ↗ |
| 2024-11-12 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 420,819 | USD 13.68 | USD 5,756,804 | SEC filing ↗ |
| 2024-11-11 | Kushner Joshua | Purchase (P) | Class A Common Stock | 276,040 | USD 13.58 | USD 3,748,623 | SEC filing ↗ |
| 2024-11-11 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | Purchase (P) | Class A Common Stock | 276,040 | USD 13.58 | USD 3,748,623 | SEC filing ↗ |
| 2021-09-16 | Schlosser Mario | Purchase (P) | Class A Common Stock | 57,300 | USD 17.53 | USD 1,004,469 | SEC filing ↗ |
| 2021-09-15 | Kushner Joshua | Purchase (P) | Class A Common Stock | 323,725 | USD 17.86 | USD 5,781,728 | SEC filing ↗ |
Form 4 evidence
98 transaction lines in the latest 365-day window; 527 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | WITTMAN VANESSA AMES | Sale (S) | Class A Common Stock | 25,000 | USD 32.24 | USD 806,000 | SEC filing ↗ |
| 2026-09-18 | Kushner Joshua | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-18 | Claremount TW, L.P.; Claremount VII Associates, L.P.; Thrive Capital Partners II, L.P.; Thrive Capital Partners III, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners II GP, LLC; Thrive Partners III GP, LLC; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | WITTMAN VANESSA AMES | Sale (S) | Class A Common Stock | 25,000 | USD 32.24 | USD 806,000 | SEC filing ↗ |
| 2026-09-18 | Kushner Joshua | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-18 | Claremount TW, L.P.; Claremount VII Associates, L.P.; Thrive Capital Partners II, L.P.; Thrive Capital Partners III, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners II GP, LLC; Thrive Partners III GP, LLC; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-03 | Schlosser Mario | Sale (S) | Class A Common Stock | 31,422 | USD 31.45 | USD 988,222 | SEC filing ↗ |
| 2026-09-03 | McAnaney Adam | Sale (S) | Class A Common Stock | 9,092 | USD 31.45 | USD 285,943 | SEC filing ↗ |
| 2026-09-03 | Liang Janet | Sale (S) | Class A Common Stock | 10,360 | USD 31.45 | USD 325,822 | SEC filing ↗ |
| 2026-09-03 | Blackley Richard Scott | Sale (S) | Class A Common Stock | 28,869 | USD 31.45 | USD 907,930 | SEC filing ↗ |
| 2026-09-03 | Baltrus Victoria | Sale (S) | Class A Common Stock | 958 | USD 31.45 | USD 30,129 | SEC filing ↗ |
| 2026-08-28 | Schlosser Mario | Sale (S) | Class A Common Stock | 150,000 | USD 30.79 | USD 4,618,500 | SEC filing ↗ |
| 2026-08-28 | Schlosser Mario | C (C) | Class A Common Stock | 150,000 | USD — | USD — | SEC filing ↗ |
| 2026-08-27 | Schlosser Mario | Sale (S) | Class A Common Stock | 600,000 | USD 30.34 | USD 18,204,000 | SEC filing ↗ |
| 2026-08-27 | Schlosser Mario | C (C) | Class A Common Stock | 600,000 | USD — | USD — | SEC filing ↗ |
| 2026-08-18 | Blackley Richard Scott | Sale (S) | Class A Common Stock | 18,750 | USD 31.74 | USD 595,125 | SEC filing ↗ |
| 2026-07-01 | Schlosser Mario | Sale (S) | Class A Common Stock | 47,500 | USD 31.24 | USD 1,484,014 | SEC filing ↗ |
| 2026-07-01 | Schlosser Mario | C (C) | Class A Common Stock | 47,500 | USD — | USD — | SEC filing ↗ |
| 2026-06-30 | Bertolini Mark T | Sale (S) | Class A Common Stock | 624,244 | USD 28.48 | USD 17,781,383 | SEC filing ↗ |
| 2026-06-29 | Bertolini Mark T | Sale (S) | Class A Common Stock | 614,752 | USD 29.26 | USD 17,985,938 | SEC filing ↗ |
| 2026-06-26 | Bertolini Mark T | Sale (S) | Class A Common Stock | 591,168 | USD 29.28 | USD 17,310,761 | SEC filing ↗ |
| 2026-06-25 | Bertolini Mark T | Sale (S) | Class A Common Stock | 615,142 | USD 28.61 | USD 17,601,317 | SEC filing ↗ |
| 2026-06-23 | Schlosser Mario | Sale (S) | Class A Common Stock | 1,027,398 | USD 29.38 | USD 30,180,344 | SEC filing ↗ |
| 2026-06-23 | Schlosser Mario | C (C) | Class A Common Stock | 977,500 | USD — | USD — | SEC filing ↗ |
| 2026-06-04 | WITTMAN VANESSA AMES | Award / grant (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-04 | Sankaran Sid | Award / grant (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-04 | Plouffe David | Award / grant (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-04 | Lang Laura W | Award / grant (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-04 | Gassen William | Award / grant (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Schlosser Mario | Sale (S) | Class A Common Stock | 34,120 | USD 21.94 | USD 748,633 | SEC filing ↗ |
| 2026-06-02 | McAnaney Adam | Sale (S) | Class A Common Stock | 9,859 | USD 21.94 | USD 216,318 | SEC filing ↗ |
| 2026-06-02 | Liang Janet | Sale (S) | Class A Common Stock | 12,475 | USD 21.94 | USD 273,716 | SEC filing ↗ |
| 2026-06-02 | Blackley Richard Scott | Sale (S) | Class A Common Stock | 31,683 | USD 21.94 | USD 695,162 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | OSCR |
| CIK | 0001568651 |
| Sector | Healthcare |
| Industry | Healthcare Plans Yahoo Finance |
| SEC SIC | 6324 Hospital & Medical Service Plans |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 527 transaction lines from 2021-03-05 to 2026-09-18 66 P purchase lines · 196 S sale lines · 265 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.